Medicare Enrolled
Dr. Harold Fite, M.D.
Anesthesiology · Longview, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fite from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fite?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fite
Dr. Harold Fite is an anesthesiology specialist in Longview, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Fite performed 2,376 Medicare services across 1,754 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fite received a total of $4,481 from 27 pharmaceutical and/or device companies across 132 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fite is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 4% volume in TX
$4,481 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,376
Medicare services
Top 4% in TX for anesthesiology
1,754
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~148 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
248 | $73 | $705 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
241 | $116 | $375 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
221 | $9 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
219 | $89 | $262 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
144 | $99 | $1,234 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
114 | $61 | $300 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
103 | $97 | $1,415 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
103 | $195 | $750 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
100 | $56 | $548 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
94 | $146 | $1,200 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
92 | $45 | $501 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
85 | $77 | $720 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
70 | $68 | $808 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
61 | $60 | $138 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
56 | $0 | $10 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
51 | $39 | $350 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
48 | $9 | $30 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
40 | $37 | $200 |
| Spinal neurostimulator electrode insertion A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system. |
37 | $239 | $3,000 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
36 | $116 | $1,591 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
34 | $66 | $658 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
32 | $79 | $300 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
30 | $141 | $1,000 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
28 | $50 | $600 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
28 | $20 | $200 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
23 | $33 | $217 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
14 | $78 | $304 |
| Anesthesia for head, neck, or upper back procedure Administration of anesthesia for surgical procedures involving the skin, muscles, or nerves of the head, neck, or upper back. |
12 | $196 | $1,242 |
| Knee nerve block injection with imaging guidance An injection of anesthetic and/or steroid medication into a nerve branch of the knee, performed using imaging guidance to ensure accurate placement. |
12 | $62 | $624 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,481
Total received (2018-2024)
Avg $640/year across 7 years
Top 8% in TX for anesthesiology
27
Companies
132
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,038 (90.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$275 (6.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$169 (3.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$375
2023
$288
2022
$799
2021
$589
2020
$119
2019
$1,107
2018
$1,204
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Nevro Corp.
$1,464
Medtronic, Inc.
$745
Abbott Laboratories
$451
SPR Therapeutics, Inc
$331
Stimwave Technologies Incorporated
$275
Saluda Medical Americas, Inc.
$238
Medtronic USA, Inc.
$203
Allergan, Inc.
$130
ABBVIE INC.
$65
PFIZER INC.
$55
Allergan Inc.
$51
Amgen Inc.
$50
Teva Pharmaceuticals USA, Inc.
$47
Boston Scientific Corporation
$44
Novartis Pharmaceuticals Corporation
$40
AstraZeneca Pharmaceuticals LP
$37
BioDelivery Sciences International, Inc.
$35
Spinal Simplicity, LLC
$34
Vertiflex, Inc.
$30
Purdue Pharma L.P.
$28
BOSTON SCIENTIFIC CORPORATION
$26
Pernix Therapeutics Holdings, Inc.
$23
AbbVie Inc.
$19
Foundation Fusion Solutions, LLC
$18
ASSERTIO THERAPEUTICS, Inc.
$16
Horizon Therapeutics plc
$15
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 59.4% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · Accurian · Aimovig · Axium INS DRG IPG · BELBUCA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · DRG IPGs · Evoke · Evoke SCS · FLECTOR · GENERAL - PAIN MANAGEMENT · Gralise · HA MINUTEMAN G3-R · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · KYPHON Balloon Kyphoplasty · LYRICA · MOVANTIK · Octrode SCS Leads · Omnia · PROCLAIM · Proclaim DRG IPG · Proclaim Family of SCS IPGs · QULIPTA · RAYOS · RESTORE · REYVOW · SCS IPGs · SPECTRA WAVEWRITER · SPRINT PNS System · STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS · SUPERION · SYMPROIC · SYNCHROMED · Senza · Senza Spinal Cord Stimulation System · SlimTip lead DRG Lead · Superion · Superion ISS · VANTA ADAPTIVESTIM · ZOHYDRO ER
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for anesthesiology in TX.
Equivalent to $189 per 100 Medicare services performed
Geographic Context
Anesthesiologists within 10 mi
22
Per 100K population
17.6
County median income
$64,809
Nearest hospital
CHRISTUS GOOD SHEPHERD MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Fite is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), with low-engagement industry engagement in the top 8% of TX peers, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Fite experienced with injection into lower spine canal with imaging guidance?
Based on Medicare claims data, Dr. Fite performed 248 injection into lower spine canal with imaging guidance services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fite receive payments from pharmaceutical companies?
Yes. Dr. Fite received a total of $4,481 from 27 companies across 132 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fite's costs compare to other anesthesiologists in Longview?
Dr. Fite's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fite) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Anesthesiologists in Longview
Browse anesthesiologists in Longview ranked by procedure volume and transparency data.
Highest volume
Top Anesthesiologists in TX
Anesthesiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Anesthesiologists in TX
Which TX anesthesiologists receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology